AQP5 overexpression did not activate the PI3K/AKT signaling pathway in breast cancer cell lines, as evidenced by the lack of increase in levels of phosphorylated AKT and the pAKT/AKT ratio. This evidence concerns the gene AQP5 and breast carcinoma.